Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay

Phytomedicine

Volumn 13, Issue 9-10, 2006, Pages 643-650

  Long, S R ^a   Carey, R A ^a   Crofoot, K M ^a   Proteau, P J ^a   Filtz, T M ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Anti arrythmic activity; Cardiomyocyte assay; Crataegus oxyacantha (hawthorn)

Indexed keywords

ADRENALIN; CARDIOVASCULAR AGENT; CRATAEGUS EXTRACT; HEARTCARE; MILRINONE; OUABAIN; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CELL ACTIVITY; CHROMATOGRAPHY; CHRONOTROPISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRATAEGUS; DRUG ACTIVITY; DRUG EFFECT; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HEART; HEART CELL CULTURE; HEART RHYTHM; MOUSE; NEWBORN; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOVASCULAR AGENTS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRATAEGUS; MICE; MYOCYTES, CARDIAC; PLANT EXTRACTS;

CRATAEGUS; CRATAEGUS MONOGYNA; MURINAE; STROPHANTHUS GRATUS;

EID: 33750528551     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.01.005     Document Type: Article

References (20)

1. Ammon H.P., and Handel M. Crataegus, toxicology and pharmacology. Part II: Pharmacodynamics (author's translation of title). Planta Med. 43 (1981) 209-239
2. Chen Z.Y., Zhang Z.S., Kwan K.Y., Zhu M., Ho W.K., and Huang Y. Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci. 63 (1998) 1983-1991
3. Hobbs C., and Foster S. Hawthorn: a literature review. HerbalGram 22 (1990) 19-33
4. Joseph G., Zhao Y., and Klaus W. Pharmacologic action profile of Crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart (author's translation of title). Arzneimittelforschung 45 (1995) 1261-1265
5. Kim S.H., Kang K.W., Kim K.W., and Kim N.D. Procyanidins in Crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci. 67 (2000) 121-131
6. Leuchtgens H. Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study (author's translation of title). Fortschr. Med. 111 (1993) 352-354
7. Muller A., Linke W., and Klaus W. Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes. Planta Med. 65 (1999) 335-339
8. Petkov V. Plants with hypotensive, antiatheromatous and coronarodilatating action. Am. J. Chin. Med. 7 (1979) 197-236
9. Pittler M.H., Schmidt K., and Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am. J. Med. 114 (2003) 665-674
10. Polinger I.S. Separation of cell types in embryonic heart cell cultures. Exp. Cell Res. 63 (1970) 78-82
11. Popping S., Rose H., Ionescu I., Fischer Y., and Kammermeier H. Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 45 (1995) 1157-1161
12. Rigelsky J.M., and Sweet B.V. Hawthorn: pharmacology and therapeutic uses. Am. J. Health Syst. Pharm. 59 (2002) 417-422
13. Schussler M., Holzl J., and Fricke U. Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 45 (1995) 842-845
14. Schwinger R.H., Pietsch M., Frank K., and Brixius K. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. J. Cardiovasc. Pharmacol. 35 (2000) 700-707
15. Tauchert M., Gildor A., and Lipinski J. High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure. Herz 24 (1999) 465-474 (discussion 475)
16. Toraason M., Luken M.E., Breitenstein M., Krueger J.A., and Biagini R.E. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart. Toxicology 56 (1989) 107-117
17. Wagner H., and Grevel J. Cardioactive drugs IV. Cardiotonic amines from Crataegus oxyacantha (author's translation of title). Planta Med. 45 (1982) 98-101
18. Walker A.F., Marakis G., Morris A.P., and Robinson P.A. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother. Res. 16 (2002) 48-54
19. 2 toxicity. Am. J. Physiol. 276 (1999) H167-H175
20. Zapfe jun G. Clinical efficacy of Crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 8 (2001) 262-266